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Vesicular stomatitis virus (VSV) induces an early T  cell-independent neutralizing IgM response 
that is followed by a long-hved, T  cell-dependent IgG response. We used the specific amplifi- 
cation factor of several 100￿  of VSV-virions for immunohistology to analyze the localization 
ofVSV-specific B cells at different time points after immunization. At the peak of the IgM re- 
sponse (day 4), VSV-specific B cells were predominantly present in the red pulp and marginal 
zone but not in the T  area. These B cells were mostly stained in the cytoplasm, characterizing 
them as antibody secreting cells. By day 6 after immunization, germinal centers (GC) contain- 
ing surface-stained VSV-specific B  cells became detectable and were fully estabhshed by day 
12. At the same time, large VSV-specific B cell aggregates were present in the red pulp. High 
numbers ofVSV-specific GC associated with persisting antigen were present 1 mo after immu- 
nization and later, i.e., considerably longer than has been observed for haptens. Some GC, ex- 
hibiting follicular dendritic  cells and containing VSV-specific, prohferating B  cells were still 
detectable up to 100 d after immunization. Long-hved GC were also observed after immuniza- 
tion with recombinant VSV-glycoprotein in absence of adjuvants. Thus some anti-virally pro- 
tective (memory) B cells are cychng and locally proliferate in long-hved GC in association with 
persisting antigen and therefore seem responsible for long-term maintenance of elevated anti- 
body levels. These observations extend earlier studies with carrier hapten antigens in adjuvant 
depots or complexed with specific IgG; they are the first to show colocalization of antigen and 
specific memory B  cells and to analyze a protective neutralizing antibody response against  an 
acute viral infection. 
B 
cell memory is characterized by (a) the presence ofiso- 
type-switched memory B  cells and  (b)  elevated levels 
of specific  antibody.  After  reexposure  of the  host  to  a 
pathogen,  secondary B  cell responses are generated more 
rapidly and produce higher antibody titers than primary B 
cell responses. Not the presence of memory B cells as such, 
but antibody titers available  before secondary exposure are 
the most powerful strategy to cope with secondary infec- 
tion, since it may allow the elimination of a given pathogen 
even  before  an  actual  infection  occurs  (1,  2).  There  is 
strong evidence that the maintenance of such memory Ig 
titers  is  dependent upon  the  presence  of specific antigen 
persisting on follicular dendritic cells (FDC) 1 (3-6). How- 
ever, it remains controversial whether or not the survival of 
memory B cells needs the continuous presence of persisting 
1  Abbreviations used in this paper: AFC, antibody  forming  cell; FDC, follicu- 
lar dendritic cells; GC, germinal centers; TBS, Tris buffered  saline; VSV, 
vesicular stomatitis virus; VSV-IND, VSV serotype Indiana; VSV-NJ, 
VSV serotype  New Jersey. 
antigen. It has been shown that memory B cells die offrap- 
idly upon adoptive transfer into antigen-free hosts  (7,  8), 
supporting the concept of antigen dependence of memory 
B cells. On the other hand, phycoerythrin-specific memory 
B  cells have been shown not to proliferate or proliferating 
only  minimally,  suggesting  a  more  antigen-independent 
type of memory B cell (9). In addition, after local viral in- 
fections, no accumulation of specific memory B  cells  has 
been found at the sites of antigen persistence. On the con- 
trary,  after acute infection in the  absence of adjuvants  or 
preexisting IgG antibodies, memory B  cells freely recircu- 
late throughout the lymphatic system independently of the 
localization of persisting antigen, excluding a strict associa- 
tion between memory B  cells and persisting antigen. This 
renders the demonstration of a strong antigen-dependence 
of memory B  cells difficult and unlikely (6). In studies us- 
ing hapten-antigen either in adjuvants or complexed with 
specific IgG, preferential accumulation of memory B  cells 
in the local lymph node has  been found (10-12).  This is 
probably due to the continuous leaking of antigen in par- 
ticular when adjuvant was used (11,  12). Also, the high fre- 
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neutralizing specific ones is probably important to keep in 
mind (26). In addition, it is important to note that some of 
the difficulties in interpretation may be due to the fact that 
some studies  did not distinguish  between  memory B  cells 
and antibody forming cells.  In contrast to these model situ- 
ations,  after  short-term  viral  infection,  memory antibody 
titers are maintained by a pool of plasma cells  that are gen- 
erated  at  the  site  of antigen  persistence  and  subsequently 
migrate to the bone marrow (6). Since most of these plasma 
cells have a rather short life span (13) and have to be gener- 
ated constantly from the pool of memory B  cells,  it is hard 
to envisage a mechanism constantly producing plasma cells 
in the  absence of some memory B  cell proliferation.  This 
study therefore attempted to analyze the protective neutral- 
izing memory B  cell localization and proliferation after an 
acute viral infection. 
We used vesicular stomatitis  virus (VSV) which induces 
a  potent  antibody response  early  after  immunization  as  a 
model antigen.  Neutralizing glycoprotein (G)-specific IgM 
antibodies  are induced in the  absence of T  help  and peak 
around day 4. Neutralizing IgG antibodies become detect- 
able around day 6 and peak titers are reached within a few 
days usually between day 8 and 12. This antibody response 
is critical for the survival of the host both in a primary and a 
secondary infection. Although the anti-VSV B cell response 
is very rapid, it represents a true primary B cell response and 
neither T  nor B  cells are preprimed by cross-reactive envi- 
ronmental  antigens.  Cross-reactive  T  help  induced  by  a 
second  serotype  of VSV  is  short-rived  and  does  not  en- 
hance the neutralizing IgG response for more than 2-3 wk 
(14).  Accidentally  cross-reactive  T  help  is  therefore  un- 
likely  to play a  role  in  the  VSV-specific  B  cell  response. 
The presence of VSV-specific primed B  cells  in naive ani- 
mals is also very unlikely since (a) nu/nu mice that do not 
have memory B cells due to the absence ofT help produce 
normal IgM levels upon immunization with VSV, (b) neu- 
tralizing IgG antibodies are detectable 2-4 d after challenge 
infection in the presence  of experimentally  induced VSV- 
specific memory B  cells  (naive mice mount detectable IgG 
titers  only by day 6-8  after immunization),  and  (c)  VSV- 
neutralizing  IgG  antibodies  from  the  early  immune  re- 
sponse are in germline  configuration (15,  and U.  Kalinke, 
unpublished  observation);  since  memory  B  cells  exhibit 
hypermutated VDJ-regions  (16,  17)  the absence of hyper- 
mutation  is  strong evidence for an  absence  of memory B 
cells.  In addition,  sentinel  mice kept  together with  VSV- 
infected  mice  do not produce detectable  neutralizing anti- 
bodies;  VSV,  therefore,  is  not  an  antigen  common in  the 
mouse house facility,  spreading from infected to non-infected 
mice. 
VSV is a cytolytic virus that does not persist in an infec- 
tious form in mice. No infectious virus particles can be iso- 
lated  from  adult  normal  mice  upon  peripheral  infection 
with usually 2  ￿  106 PFU (18,  19); viral RNA can only be 
detected  for 24  h  by sensitive  PCR  techniques  detecting 
~10-40  copies  per  spleen,  liver,  or lung  (U.  Hoffmann, 
unpublished observations). 
We used VSV-virions as a specific amplification step for 
immunohistology and analyzed the VSV-specific B  cell re- 
sponse  in  the  spleen  after  primary  immunization.  This 
novel approach permitted following the VSV-specific anti- 
body-producing B  cells  and  antigen  in parallel.  GC  con- 
taining VSV-specific B cells were present by day 6 after im- 
munization and maximal numbers of GC were reached by 
day 8.  GC specific for VSV were long-lived and could be 
detected  more  than  3  mo  after immunization.  These  GC 
contained VSV-specific B  cell blasts that proliferated in as- 
sociation with  FDC and persisting antigen.  These findings 
suggest  that  persisting  antigen-associated  memory B  cells 
proliferate  and  differentiate  into  antibody forming cells  to 
maintain elevated levels of memory IgG antibodies. 
Materials and Methods 
Mice and  Viruses.  C57BL/6  mice  were  obtained  from  the 
breeding colony of the Institut flir Zuchthygiene (Ztirich,  Swit- 
zerland).  VSV Indiana (VSV-IND; Mudd-Summers isolate)  and 
VSV New Jersey (VSV-NJ;  Pringle isolate)  had been originally 
obtained from Professor  D.  Kolakofsky (University of Geneva, 
Switzerland).  Both strains were grown on baby hamster kidney 
(BHK)  21  cells infected with low multiplicity of infection and 
plaqued on Vero cells (20). All experiments were performed us- 
ing VSV-IND unless  stated  otherwise.  The recombinant bacu- 
lovirus  expressing  the glycoprotein of VSV-IND was a generous 
gift of Dr. D.H.L. Bishop (NERC Institute  of Virology, Oxford, 
UK).  It  was  derived  from  nuclear  polyhedrosis  virus  and  was 
grown at 28~  in Spodoptera frugiperda cells in spinner  cultures 
in TC-100 medium (21). 
Preparation of Recombinant  Viral Proteins.  To produce viral pro- 
teins, Spodoptera frugiperda cells at a density of 2 ￿  106 cells/ml 
were infected with recombinant baculoviruses  expressing the gly- 
coprotein of VSV with a multiplicity of  infection of 10 for 24 h at 
28~  Infected cells were harvested,  disrupted  by sonication,  and 
stored at -20~ 
The presence of antigen was confirmed by Western blot analy- 
sis and concentration of  proteins was estimated by SDS gel analysis. 
Serum  Neutralization  Test.  Serum was collected from mice at 
specific time points after VSV infection. The sera were prediluted 
40-fold in minimal  essential medium containing 5% FCS,  then 
heat-inactivated for 30 min at 56~  Serial twofold dilutions  were 
mixed with equal volumes of  VSV diluted to contain 500 pfu/nd. 
The mixture was incubated for 90 rain at 37~  in an atmosphere 
with 5% CO2. 100 l~l of the serum-virus mixture was transferred 
onto Vero cell monolayers in 96-well plates and incubated for 1 h 
at  37~  The  monolayers were  then  overlaid  with  100  I~l  of 
DMEM  containing  1%  methyl  cellulose.  After  incubation  for 
24 h at 37~  the overlay was flicked  off and the monolayer was 
fixed and stained with 0.5% crystal violet.  The highest dilution of 
serum that reduced the number of plaques  by 50% was taken as 
titer.  Because  the addition of an equal  volume of virus,  the titer 
of serum was considered to be one step higher. To determine IgG 
titers,  undiluted serum was pretreated  with an equal  volume of 
0.1 mM [3-mercaptoethanol in saline (22). 
Enumeration  of Antibody-forming  Cells.  Antibody-forming  cells 
specific  for VSV-IND  were  enumerated  as  described  (23). In 
brief,  25-well plates  (Greiner,  Germany) were coated overnight 
with purified VSV-IND. After a blocking step, single cell suspen- 
sions of spleen  cells were added and incubated for 5 h  at 37~ 
Plates were washed and incubated with goat anti-mouse IgG an- 
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rabbit anti-goat antibodies.  Antibody spots were developed with 
alkaline  buffer solution  (Sigma  Chemical Co.,  St.  Louis,  MO) 
containing 5-bromo-4-chloro-3-indolyl phosphate (100 rag/100 
ml) mixed with 3% agarose in distilled water (4:1). 
ELISA.  96-well plates (Petra Plastic, Switzerland)  were incu- 
bated with purified VSV-specific  monoclonal antibody VI10 (0.1 
Ixg/well)  or an irrelevant,  isotype-matched control antibody (0.1 
I.tg/ml)  in 0.1  M  NaH2PO4, pH 9.6,  at  4~  Plates  were then 
blocked with 2% BSA in PBS for 2 h, washed,  and then serial di- 
lutions of VSV were added to the wells and then incubated for 
1 h.  Plates  were washed and incubated with biotinylated VSV- 
specific monoclonal antibody VI22 for 1 h. Plates  were washed 
and incubated with peroxidase-labeled  Streptavidin  (Tago, Bur- 
lingame, UK). After 1 h, plates were washed and developed with 
ABTS  (5  mg 2,2'-azino-di-3-ethyl-benzthiazolinesulfonate and 
20 tzl H202 in 50 ml NaHCO3, pH 4.0). Optical density was de- 
tenmned at 405 nm. 
Immunohistology.  Freshly  removed organs  were immersed in 
Hank's balanced salt solution and snap frozen in liquid nitrogen 
by submersing the specimens for a few minutes. Tissue sections of 
5 Ixm thickness  were cut in a cryostat,  placed on siliconized  glass 
slides,  air  dried,  fixed  with  acetone for  10  rain,  and  stored  at 
-  70~ 
Immunohistological Staining.  If not stated  otherwise, immuno- 
histological  reagents  were  purchased  from  DAKO  (Glostrup, 
Denmark).  Secondary affinity-purified  polyclonal anti-immuno- 
globulin antisera were diluted in Tris-buffered saline (TBS) con- 
taining 5% normal mouse serum. All other dilutions  were made 
in TBS. Incubations were performed at room temperature for 30 
min; TBS was used for all washing steps. Sections were counter- 
stained  with hemalum and coverslips  were mounted with glyc- 
erol/gelatin. 
Detection of VSV-specific B Cells.  Dehydrated  tissue  sections 
were overlaid with a solution of UV light-inactivated VSV (3 X 
106 pfu/ml before inactivation)  for 4 h. Specifically bound virus 
was detected by incubation with polyclonal rabbit anti-VSV-IND 
serum (diluted  1:1,500;  the antiserum had a neutralizing titer of 
> 1:10s), followed by alkaline phosphatase-labeled  goat antibodies 
to rabbit immunoglobulins and rabbit anti-goat immunoglobulin 
antibodies  (diluted  1:80; Jackson  ImmunoResearch Labs.,  Inc., 
West  Grove,  PA).  Alkaline  phosphatase  was  visualized  using 
naphtol AS-BI phosphate and New Fuchsin as substrate,  which 
yields  a  red  precipitate.  Endogenous  alkaline  phosphatase  was 
blocked by levamisole. 
Double  Staining for  VSV-spedfic  B  Cells and  DNA-incorporated 
BrdU.  The  double  staining  was  essentially  performed  as  de- 
scribed  (24). For the detection ofVSV-specific B cells, the proce- 
dure as described above was used. The substrate used for alkaline 
phosphatase  was  naphtol  AS-MX phosphate  and  Fast-Blue  BB 
salt, yielding a blue precipitate.  Sections  were then treated with 
1 M  HC1 for 20 min to denature the DNA and to terminate the 
immunoenzymatic reaction without displacing  the blue reaction 
product.  Slides were  then  incubated  with  the  monoclonal  rat 
anti-BrdU antibody BU1/75. This rat antibody was revealed by 
sequential  incubation with rabbit antibodies  against rat-immuno- 
globulins  and rat  APAAP-complex (diluted  1:50;  applied  three 
times).  Alkaline  phosphatase  was visualized  with naphtol AS-BI 
phosphate and New Fuchsin (red precipitation product). 
PNA-binding and Staining of Other Markers.  Sections were in- 
cubated with PNA (diluted  1:200) and bound PNA was detected 
by rabbit anti-PNA antibodies  (diluted  1:300) followed by alka- 
line phosphatase-labeled  antibodies  to rabbit immunoglobulins (1: 
300;  TAGO). Rabbit antisera  against mouse IgM and IgG were 
used for the demonstration of mouse immunoglobulins. CD4 was 
detected  by the  rat  monoclonal antibody YTS191  (ascites was 
kindly provided by Dr.  H. Waldman,  Oxford, UK; dilution  1: 
6,000).  For follicular  dendritic cell staining,  sections  were incu- 
bated  with  1:300  diluted  afffinity-purified  monoclonal rat  anti- 
body 4Cll  (25). Primary antibodies  were detected using a double 
sandwich staining  technology. Alkaline  phosphatase-labeled  goat 
antibodies  to  rabbit  immunoglobulins  or rat  immunoglobulins, 
respectively  (Jackson ImmunoResearch Labs.), were diluted 1:80, 
applied  for 30 min and followed by alkaline phosphatase-labeled 
donkey antibodies  against goat immunoglobulins (TAGO) diluted 
1:80 for another  30  min.  Naphtol AS-BI phosphate  and New 
Fuchsin were used for the color reaction. 
Detection of Persisting ViraI Antigen.  Sections  were  incubated 
with a rabbit anti-VSV-G antiserum  (diluted  1:1,000) for 30 min. 
Affinity-purified alkaline  phosphatase-labeled  goat antibodies  to 
rabbit  immunoglobulins were diluted  1:80,  applied  for 30 min, 
and followed by alkaline  phosphatase-labeled  donkey antibodies 
against  goat immunoglobulins diluted  1:80 for another 30 min. 
Alkaline phosphatase  was detected using Nitro Blue Tetrazolium 
(Sigma) and 5-bromo-4-chloro-3-indolylphosphate (NBT) BCIP 
as  a  substrate.  Sections  were  counterstained  with  Kernechtrot 
0.1%  for 3 min;  the NBT/BCIP reaction is  considerably  more 
sensitive than the Napthol AS-BI phosphate reaction. 
Results 
VSV-specific  B  Cell  Response:  Neutralizing  Antibodies  and 
Antibody-forming Cells (AFC).  Mice were immunized with 
VSV and the neutralizing B  cell response was followed for 
100 d and VSV-specific AFC frequencies were determined 
(Fig.  1). Neutralizing IgM antibody titers were maximal by 
around day 4  confirming earlier results and IgG antibodies 
appeared by day 6.  Neutralizing IgG levels reached maxi- 
mal levels by day  12-20 and stayed at a high titer for the 
time period measured (Fig.  1 B). Frequencies of VSV-spe- 
cific IgG producing AFCs were maximal around day 8, de- 
clined relatively rapidly between  day 8  and day 20,  disap- 
peared slowly thereafter but were still detectable t00 d after 
immunization  (Fig.  1 A).  The  relatively more  drastic  de- 
crease  of the  AFC frequencies  compared  to  the  antibody 
titer has been discussed in detail elsewhere and can be ex- 
plained by the rapid proliferation of specific B  cells during 
the  early phase of the immune response  and an increasing 
proportion of AFCs present in the bone marrow at the later 
time points  (6,  26).  Thus,  VSV induces a long-lived neu- 
tralizing  antibody  response  along  with  an  increased  fre- 
quency of VSV-specific antibody forming cells.  Live virus 
is not necessary for this type of response, since recombinant 
VSV-glycoprotein induces a similar response (not shown). 
Histological Detection of VS V-specific B  Cells.  In an attempt 
to analyze the VSV-specific B cell response in situ, a method 
to detect VSV-specific  antibodies  was developed  in vitro. 
ELISA plates  were coated with  purified monoclonal VSV 
neutralizing antibody VI10 (15) and incubated with graded 
amounts of VSV particles. Bound VSV was detected with a 
biotinylated VSV-specific monoclonal antibody VI22. VSV 
was used either as purified virus or as non-purified stock vi- 
res;  both  virus  preparations  gave  comparable  results  (Fig. 
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Figure 1.  VSV-specific  antibody response. Mice were immunized with 
VSV (2 X 106 PFU) and the number of specific IgG-producing AFCs was 
determined at the indicated time points (A). Neutralizing IgM (squares) 
and IgG (triangles) titers were determined ~om 40-fold prediluted sera (/3). 
The mean of three mice is shown at all time points. Variations in A were 
smaller 30%; in B, variations were smaller than two dilution steps. 
2).  Thus,  VSV virions could be used as a specific probe to 
detect  VSV-specific  antibodies.  A  similar  method  as  this 
catcher ELISA was used to detect VSV-specific B  cells ex- 
pressing  VSV-specific  antibodies  in  the  spleen  of immu- 
nized  mice  (Fig.  3).  Spleen  cell  sections  were  incubated 
with VSV used for specific amplification  and bound  virus 
was detected  with  a  VSV-specific  antibody.  A  polyclonal, 
VSV-specific  rabbit serum was used  and  subsequently  de- 
tected with phosphatase-labeled secondary antibodies. 
4  d  after i.v. immunization,  spleen sections were stained 
for PNA-binding  (Fig.  3 A)  for FDCs  (B), VSV-specific B 
cells (C), IgG (D), CD4  (E), and IgM (it:). VSV-specific B 
cells  were  predominantly  found  in  the  red  pulp  and  the 
marginal zone areas with some specific B  cells scattered in 
the B  cell follicles and very few B  cell in T-areas (Fig.  3  C 
and see Fig. 6). Many of the VSV-specific cells were stained 
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Figure  2.  Detection  of VSV- 
specific  antibodies  by  ELISA. 
ELISA  plates  were  coated  with 
purified rnonoclonal VSV  neu- 
tralizing  antibody  VI10  (open 
symbols)  or an isotype matched, 
irrelevant  antibody  (closed sym- 
bols) and incubated with twofold 
serial dilutions of purified virus 
(squares)  or  non-purified  stock 
virus (circles). Bound  virus was 
detected  with  VSV-G-specific 
biotinylated  monoclonal  anti- 
body VI22. 
in the  cytoplasm, suggesting that they were secreting anti- 
body. No stained cells could be detected on spleen sections 
from non-immunized mice (not shown).  At this early time 
point, no VSV-specific GC could be observed and no IgG- 
expressing  B  ceils  were  found  in  IgM  positive  follicles. 
Since almost no VSV-specific IgG producing B  cells can be 
detected on day 4 of the response, the stained B  cells in Fig. 
3  C apparently produce IgM. On day 2 after immunization, 
only very few VSV-specific B cells could be found (Fig. 4 A). 
Induction  of GC.  On  day  4  after  immunization,  GC 
were absent as seen by both lack of PNA binding and FDC 
accumulations  (Fig. 3, A  and B). By day 6 after immuniza- 
tion,  GC  became  detectable  (Fig.  4  B)  and  increased  in 
numbers until day 8-12  (Fig.  5). On day 12, the GC were 
PNA  positive  (Fig.  3  G),  exhibited  grouped  FDC  (Fig.  3 
H),  VSV-specific  B  cells  (Fig.  3  t),  some  CD4 +  T  cells 
(Fig.  3  L)  and  lightly  surface  IgM-positive  cells  in  GC 
clearly distinct  from the  IgM positive mantle  zone  B  cells 
(while they were also B220 positive, not shown)  and mar- 
ginal  zone B  cells  (Fig.  3  M).  In addition,  many IgG ex- 
pressing B  cells were present in GC (Fig. 3  K). The local- 
ization of FDC scattered on day 4 and well centered in GC 
after  day  6  is  very striking  (Fig.  3,  B,  H,  O).  Almost  all 
VSV-specific GC B  cells only stained on the cell surface. In 
Fig. 4  C, a higher magnification  of a day 12 spleen section 
is shown in which surface stained GC B  cells (leti side) can 
clearly be  distinguished  from  more  intensely,  cytoplasmi- 
cally  stained  non-GC  B  cells  on  the  right  side.  The  in- 
tensely  stained  B  cells  within  aggregates  in  the  red  pulp 
outside of GC did not bind PNA as assessed on an adjacent 
section (not shown). 
Great numbers of GC were still present 3 wk to 1 mo af- 
ter immunization  (Fig. 4 D) and some GC were detectable 
even  100  d  after  immunization  (not  shown  and  Fig.  5). 
These late  GC were  still well defined  and  associated with 
follicular dendritic  cells (not shown). 
Control  spleens  from  non-immunized  mice  or  from 
mice  reconstituted  with  polyclonal  anti-VSV-specific  se- 
rum did not reveal any specific staining (not shown).  Neu- 
tralizing  antibodies  do  not  cross-react  by  definition  be- 
tween  VSV  serotype  Indiana  and  serotype  New  Jersey 
whereas non-neutralizing,  binding antibodies cross-react to 
some  extent  (27,  28).  A  good  specificity control  was  that 
spleen  sections  from mice immunized  with  VSV  serotype 
New Jersey  showed  no  significant  staining  distinct  from 
non-immunized  mice  when  VSV  serotype  Indiana  was 
used  for  the  amplification  step,  suggesting  that  this  assay 
dominantly detects neutralizing antibodies  (not shown). 
VSV  does  not  replicate  measurably  extraneuronally  in 
normal adult mice and since it is cytolytic, it is unlikely that 
it  persists  latendy  in  infected  cells  (19).  We  nevertheless 
tested whether the long-lived GC were dependent upon an 
infectious  form of VSV-G  or not.  Mice  were  immunized 
intravenously  with  recombinant  VSV-G  protein  (10  Ixg) 
and spleen sections were stained 1 mo later for the presence 
of VSV-specific  B  cells.  As  with  live  virus,  spleens  from 
mice  immunized  with  recombinant  VSV-G  exhibited 
well-defined GC (not shown)_ 
2262  VSV Induces Long-lived Germinal Centers Figt~ra  3.  Localization ofVSV-specific B  cells upon immunization with VSV.  Mice were immumzed with VSV (2 ￿  106  PFU) and adjacent spleen 
sections were stained 4 d  (A-F) or 12 d  (G-P) later. The stained quality is indicated in each panel. PNA, peanut hemagglutitin binding; FDC, follicular 
dendritic cells;  VSV-spec. B, VSV-binding B  cells;  IgG, IgG positive cells;  CD4, CD4 positive cells;  IgM, IgM positive cells;  PALS, periarteriolar lym- 
phatic sheath; F, follicle; MZ, marginal zone; RP, red pulp;  GC, germinal center; FM, follicular mantle zone.  1 corresponding to dark zone and 2 corre- 
sponds to light zone of GC in N-P (see text). Bars: (A-M and N-P) 100 ~m. Original magnification: A-M, ￿  110; N-P,  ￿  140. 
2263  Bachmann et al. Figure 4.  Histological analysis  ofVSVospecific B cell responses: Induction of  long-lived GC associated with persisting antigen and containing  prolifer- 
ating B cells. Mice were immunized  with VSV (2 ￿  106 PFU) and spleen sections were stained 2 d (A), 6 d (B), or 12 d (C3 later for VSV-specific B cells. 
Spleen sections of mice immunized 30 d before with UV-inactivated lysates of infected cells (i.e., one dose of non-replicating  antigen) were stained for 
VSV-specific B cells (D). Persisting VSV-antigens were detected on an adjacent section with a rabbit anti-VSV-G  serum and a very sensitive alkaline 
phosphatase labeled goat anti-rabbit antibody plus a third stage antibody. Sections were developed with NBT/BCIP yielding a black reaction product 
(E). The same staining with a normal rabbit serum was negative. A second adjacent section was stained for FDC (F). Although D, E, and F are not quite 
identically oriented, the central arteriole and the FDC clumps seen in F can be used to compare the sections. In G-I, mice were immunized with VSV (2 
X 106 PFU) and 16 h before analysis,  2 mg BrdU was injected intraperitoneally. Spleen cell sections were doubly stained (half-open, half-dosed triangle) for 
VSV-specific B cells (blue, open triangle) and BrdU (red, closed  triangle) 8 d (G), 30 d (H), or 100 d (/) after immunization. Even 100 d after immunization, 
some VSV-specific B cells had incorporated BrdU within 16 h. For abbreviations see Fig. 3 legend. Bars: (A, B, and C-F): 100 ixm; G-I, 30 ~m. Origi- 
nal magnifications: A and B, ￿  C-F, ￿  G-l, ￿ 
Long-lived  GC Are Associated with Persisting Antigen.  As 
previously described (6), persisting antigen can optimally be 
detected  by immunohistology after immunization of mice 
with VSV-infected cell lysates. Mice were  immunized i.p. 
with 10  7 VSV infected, sonicated and UV-light inactivated 
cell lysates and 1  mo later, persisting VSV-G was  detected 
using a specific rabbit anti-VSV-G serum (Fig. 4  E). As ex- 
pected,  sites of antigen persistence cotocalized with FDCs, 
as revealed by FDC-specific staining of an adjacent section 
(Fig.  4  F).  On  a  second  adjacent section,  VSV-specific  B 
cells  were  stained,  demonstrating that  the  same  GC  con- 
tained  persisting  VSV  antigens  and  VSV-specific  B  cells 
(Fig.  4  D).  For this staining, the following practical prob- 
lem had  to  be  solved:  VSV-specific B  cells are  stained by 
detecting  viral  particles  bound  to  specific  B  cells  with  a 
polyclonal  rabbit  anti-VSV  serum.  Persisting  antigen,  on 
the  other  hand,  is  detected  similarly with  a  rabbit  anti- 
VSV-G serum.  Thus, we had to be able to  distinguish be- 
tween viral particles bound to specific B  cells and viral anti- 
gens persisting on FDCs. VSV particles bound to specific B 
cells represent  a  rather  sizable  concentration of viral anti- 
gens  considerably  greater  in  amounts  than  VSV  antigens 
persisting on FDCs.  We  therefore  were  able to  selectively 
use staining conditions that were  only sensitive enough to 
reveal  viral particles  bound  to  specific  B  cells  that  were, 
however,  not sufficient to  stain FDC-associated  persisting 
antigen. This was done by (a)  using a very high titered rab- 
bit serum for detection of persisting antigen and a different, 
lower titered one for detection of B  cell-bound viral parti- 
cles and (b)  using two  different color reactions,  the greater 
sensitivity of the NBT/BCIP  for detection of persisting an- 
tigen  versus  the  less  sensitive AS-BI  phosphate  and  New 
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that in Fig. 4 D  indeed VSV-specific B cells were detected 
and  not  persisting  viral  antigens,  a  control  section  was 
stained as in Fig.  4  D,  except that no viral particles were 
added  (not shown).  As expected, no specific staining was 
revealed,  confirming that  VSV-specific  B  cells  were  de- 
tected in Fig.  4  D.  Thus,  GC containing VSV-specific B 
cells colocalize with persisting antigen bound on FDCs. 
Characterization  of GC.  Mouse  GC B  ceils bind PNA. 
In addition, they colocalize with FDCs, which present na- 
tive antigen to specific B cells (for review see reference 29). 
In Fig.  3  P,  two  GC containing VSV-specific B  cells  are 
shown 12 d after immunization; in addition, there is a clus- 
ter of specific B cells in the red pulp (top, to the right side). 
In Fig. 3, N  and O adjacent sections were stained for PNA 
binding  and  FDCs,  respectively. As  expected,  the  VSV- 
specific B  cells in GC bound PNA  (Fig.  3 N) but did not 
express IgD (not shown) and colocalized with FDCs (Fig. 3 
O).  In contrast, the B  cells  of the  cluster in the red pulp 
(Fig. 3 P) did not bind PNA. 
The fine architecture of GC  as has been described for 
hapten-specific  immune  responses  and  human  GC  (29). 
Although less clear,  they were also  found here for VSV- 
specific GC. Accordingly, a zone 1 (dark zone) containing 
centroblasts that do bind only little antigen (Fig.  3 P) but 
bind PNA  (Fig.  3 N)  and do not colocalize with the fine 
mesh-forming FDCs  (Fig.  3  O)  and a zone 2  (light zone), 
containing centrocytes that do bind the antigen and colo- 
calize with FDCs was observed. Occasionally, few B  cells 
binding VSV  on the surface and also  intracellularly could 
be  observed in  the  zone  1  (Fig.  3  P).  The relevance or 
function of these B cells is not known; it is conceivable that 
these cells are freshly induced plasma cells leaving the GC. 
VSV-specific B cells in GC of spleens from mice immu- 
nized 100 d previously did also bind PNA and colocalized 
with  FDCs  (not shown).  Interestingly, the distribution of 
FDCs was  not uniform, but FDCs predominated on one 
side of the GC (Figs.  3  O  and 4  F).  It is also noteworthy 
that although the network of FDCs was dominant on one 
side of the GC, some areas of densely packed FDCs could 
be seen on the border where dark and light zone meet and 
also  within  the  dark  zone on  day  12  after immunization 
(Fig.  3,  H  and  O).  The  same  was  true  for the  late  GC 
(Fig. 4 F). 
For all sections shown in Figs. 3 and 4, adjacent sections 
were stained for PNA and FDCs (only few are shown); all 
GC were PNA positive and colocalized with FDCs. Inter- 
estingly, some GC B cells of the later time points exhibited 
intracellular staining for antibody (e.g., Fig. 4, D and it); this 
was hardly observed in day 6 (Fig. 4 B) or day 12 (Fig. 3, I 
and P  and Fig. 4  C)  GC. Apparently, the late GC B  cells 
appeared  to  have  matured  more  towards  the  plasma  cell 
phenotype. 
GC are sites  of intensive B  cell proliferation. We con- 
firmed this for VSV-specific B cells in GC of spleens from 
mice  immunized  8  d  previously.  Mice  immunized with 
VSV were treated with BrdU 7 d later (2 mg in PBS, i.p.). 
The next day,  spleens were harvested and double-stained 
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for VSV-specific B cells (blue) and BrdU incorporation (red); 
(note that the red color here denotes BrdU-positive cells 
and  blue  indicates  VSV-specific  B  cells  in  Fig.  4,  G-/). 
Nearly all VSV-specific B cells incorporated BrdU indicat- 
ing that they were proliferating (Fig. 4 G). Interestingly, 30 
and even 100  d  after immunization, VSV-specific B  cells 
(blue) of GC still incorporated BrdU (red) during the 16 h 
before fixation (Fig. 4, H and/). As already mentioned, the 
GC B cells of the late time points (Fig. 4, H  and/) exhib- 
ited a more intensive staining (blue, that in some cells is in- 
tracellular) than the only surface-stained B cells of the day 8 
GC (Fig. 4 G). 
The number of GC was  analyzed at the different time 
points after immunization (Fig.  5).  The first GC appeared 
by day 6 after immunization and some of these early GC 
were heterogeneous in size. At later time points, GC were 
much more numerous and also larger with some exhibiting 
diameters of up to 500 ~m. By day 100, the number of GC 
had  decreased considerably and very large  GC  were  not 
observed. 
Localization  of Specific B  Cells  Outside  GC.  On  day  2 
(Fig. 4 A) or day 4 (Fig. 3 C) after immunization almost no 
VSV-specific B  cells were found in the T  cell areas;  they 
were only present in the red pulp/marginal zone or as sin- 
gle ceils  in B  cell follicles (Fig.  6).  Thus, VSV-specific B 
cells seem not to be induced in the T cell areas but rather in 
the  primary B  cell  follicles  or  in  the  red  pulp/marginal 
zone. This contrasts with hapten-specific B  cell responses, 
since  hapten-specific B  cells  have been shown  to be  in- 
duced in the T  cell areas  where they can be observed as 
plasma cell foci at the edge of the T  cell areas (24, 30). Be- 
tween day 6 and day 12, most VSV-specific B ceils outside 
GC were present in the red pulp. Interestingly, this distri- 
bution had changed by 3 wk after immunization, since an 
increasing proportion of specific B cells was present as sin- 
gle cells within the follicles.  At these later time points, no 
large B cell aggregates were present in the red pulp and B 
cells  outside follicles  were often associated with the mar- 
ginal zone. These B cells probably represent marginal zone 
memory B  cells  (31).  The proportional increase of VSV- 
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Figure 5.  Number ofVSV-specific GC per spleen section. Mice were 
immunized with VSV (2  ￿  10  6 PFU) and spleen sections were analyzed 
for the presence ofVSV-specific GC. At least three sections from two dif- 
ferent mice were counted. Bars indicate  the standard error of the mean. specific follicular B  cells at these late time points  does not 
reflect  an  increase  of absolute  numbers,  since  the  total 
number of specific B  cells decreases (Fig. 6). 
Discussion 
VSV induces  a potent  antibody response  that is protec- 
tive in vivo  (26,  32).  The  early IgM response is indepen- 
dent of the presence of T  helper cells due to the repetitive 
pattern  of the  VSV-G  in  the  envelope  (33),  whereas  the 
ensuing IgG response strictly requires T  help (34). VSV in- 
duces a strong memory B  cell response with life-long high 
IgG titers. VSV differs in this respect from most other nor- 
really studied antigens, since it is both a T  cell-independent 
antigen  for IgM and  a  T  cell-dependent  antigen  for IgG. 
This,  however,  appears  to  be  a  common  characteristic  of 
many pathogens  (35-37). 
Although  the  sites  of B  cell induction  and  proliferation 
upon immunization  have been described in great detail for 
haptenated  proteins  alone,  in  adjuvants,  or  given  as  anti- 
body-complexes  and  for  haptenated  LPS  (9-13,  30,  31, 
38--40), no histological analysis of a virus-specific neutrahz- 
ing  and  protective B  cell response  has been  performed so 
far, most probably due to technical limitations.  In this study 
we analyzed the VSV-specific B  cell response using the vi- 
rus  itself as a  specific  amphfication  step  on  immunohisto- 
logical sections. 
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Figure 6.  Number ofVSV-specific B cells outside GC. Mice were im- 
munized with VSV (2 ￿  1.06 PFU) and spleen sections were analyzed for 
the presence ofVSV-specific B cells. The total number ofnon-GC B cells 
within 20 rrm~  2 is indicated in A for each time point. In B, the percentage 
orB cells in the red pulp/marginal zone (squares), B cell follicles (triangles), 
and T cells areas (diamonds) is indicated. Note the small variability in per- 
centages in B within the early (day 4 to day 12) and within the late (day 
21 to day 100) time points indicating the rehability of the assessment. 
T-dependent B  cell responses are exclusively induced  in 
the T  regions of the spleen and lymph nodes and first loci 
of antibody-producing  B  cells  were  usually  found  at  the 
contact sites of the T  region and B  cell follicles when hap- 
ten  carrier responses were studied  (24,  30,  31).  In contrast 
to  these  results,  no  significant  numbers  of VSV-specific B 
cells were found within the T  area on day 2 and day 4 dur- 
ing  the  early phase  of the  13  cell  response,  but  specific  B 
cells were found mostly in the red pulp and in B  cell folli- 
cles. As specific B  cells in the red pulp by far outnumbered 
specific B  cells in the follicles and since all of the viral anti- 
gen is found in the red pulp/marginal zone of the spleen or 
the subcapsular sinus in the lymph nodes early after immu- 
nization  (6,  41),  it is likely that B  cells were  directly acti- 
vated in  the  red pulp  or the  marginal  zone.  Although  we 
cannot formally exclude  that few early B  cells are induced 
in the follicles and subsequently migrate to the red pulp and 
proliferate, it appears that in the early response most VSV- 
specific B  cells are not induced in the T  area. This may not 
appear surprising since VSV is a strong T-independent  type 
I antigen (37) without being a polyclonal activator (42) and 
apparently induces B  cells directly and in the absence of T 
help  (33,  37).  This notion  is supported  by the fact that on 
day 4  after immunization,  VSV-specific B  cells are distrib- 
uted  similarly  in  mice  depleted  of  CD4 +  T  cells  (not 
shown).  However,  these  findings  seem to  differ from  re- 
sults obtained with haptens coupled to LPS, another type I 
T-independent  antigen  (38),  where  B  cell  activation  was 
found  to  predominantly  occur in  T  areas.  The  difference 
between  the two analyses may reflect different localization 
of antigens after immunization and/or are related to the large 
difference in  specific B  cell frequencies  of "-~10-2-10 -3 for 
some haptens versus 10 -5 for VSV-neutralizing B cells (26). 
Throughout  the  early B  cell  response,  many VSV-spe- 
cific B  cells were found in the red pulp and around termi- 
nal arterioles.  These B  cells exhibited intensive intracellular 
staining and therefore were antibody-secreting cells. This is 
consistent  with  the  finding  of very  high  frequencies  of 
AFCs at these early time points (10 -3 spleen cells). 3 wk af- 
ter  immunization  and  later,  the  proportion  of specific  B 
cells in the red pulp decreased substantially and the propor- 
tion  of specific  follicular B  cells,  that were  not  associated 
with  GC, increased.  This suggests that memory B  cells are 
not  only  found  in  the  marginal  zone  (31)  but  are  also 
present  as  follicular  B  cells  at  least  for  late  anti-VSV  re- 
sponses.  The reduced number of specific B  cells in the red 
pulp is consistent with the finding of overall decreasing fre- 
quencies of AFCs at these later time points. 
GC  appeared  as  early  as  6  d  after  immunization  with 
similar kinetics as T  help and IgG antibodies  are generated 
(14). CD4 + T  cells could be identified in VSV-specific GC 
but at this stage of the analysis we cannot define the speci- 
ficity  of the  CD4 +  T  cells.  GC  increased  rapidly both  in 
size  and  number.  At  the  peak  of the  response,  almost  all 
GC  present  in  the  spleen  contained  B  cells  specific  for 
VSV.  Many  GC  exhibited  a  typical  architecture  and  the 
previously  described  dark  and  light  zones  (29)  could  be 
identified  (Fig.  3).  This  architecture  is thought  to be cru- 
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response. It is therefore interesting to note that despite the 
occurrence of GC with a normal structure and containing 
CD4 + T  cells during the anti-VSV response, the overall af- 
finity of the antibodies does not increase after day 6 of the 
response (15).  It may be that for antigens inducing a high 
afffinity response early, as is the case for VSV, the chances 
are high that hypermutation (which is occurring and is be- 
ing analyzed; U. Kalinke, H. Hengartner, and R.M.  Zink- 
ernagel, unpubhshed observation) causes a reduction rather 
than a further increase of affinity. Somatic selection in the 
GC therefore may maintain high affinity in an equilibrated 
fashion by eliminating hypermutated clones that lowered 
or lost their specificity. Therefore, no  overall increase  of 
the already high average affinity is seen. 
GC did not disappear by 3 wk after immunization but 
remained present at high numbers;  they were still detect- 
able 100 d after immunization although fewer and no large 
GC were observed. GC were still associated with persisting 
antigen on FDC and GC B  cells were PNA  high and IgD  l~ 
(not shown), and B  cells proliferated also  at the late time 
points (Fig. 4, H  and/). These late GC were clearly differ- 
ent from the very few specific B  cell blasts found scattered 
in B  cell follicles  6--7 wk after immunization with haptens 
(24)  in  that specific B  cells were  clustered and associated 
with persisting antigens on FDC.  Many of the late GC B 
cells found 100 d after an acute VSV infection had a differ- 
ent  phenotype as  compared to  GC  B  cells  of day 8-12. 
Many B cells were not only surface positive for Ig expres- 
sion but also the cytoplasm stained for presence of specific 
antibody (Fig. 4, D and/). It therefore appeared that GC B 
cells at the later time points had differentiated towards the 
plasma cell phenotype. This suggests  that the GC may be 
involved in  antibody production and the  maintenance  of 
memory IgG titers (see below). GC B cells apparently dif- 
ferentiate to the memory cell phenotype in the presence of 
activated T helper cells (i.e., via CD40- hgand) and to the 
plasma cell phenotype in the absence of activated T  helper 
cells  (43).  Since the  memory T  helper cell response after 
VSV-  infection seems to dechne rapidly (14),  it is likely 
that GC B  cells differentiate at the later time points in the 
presence of few or even in absence of activated T  helper 
cells and differentiate to the plasma cell phenotype (see also 
reference 44). 
VSV, similar to many vaccines, induces a memory B cell 
response in the absence of a long-term depot in adjuvants 
(also in the absence of detectable viral RNA; U. Hoffmann, 
unpublished observation) and viral antigen persists  only in 
its natural form in association with FDCs. Despite the fact 
that VSV infects few cells in an abortive way after infection 
and therefore behaves like a "non-infectious" antigen, our 
findings overall contrast with kinetics of hapten-specific B 
cell responses that  are  considerably more short-lived,  de- 
spite the use of adjuvants or of preformed antigen-antibody 
complexes. Nevertheless, to overcome the potential prob- 
lem that undetected VSV genetic information may main- 
tain  antigen  supply,  experiments were  repeated with  re- 
combinant VSV-G protein, injected i.v. or subcutaneously 
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in the absence of adjuvants with comparable resuks. Thus 
the induction of  long-lived GC was independent of the use 
of a replicating agent but most probably dependent on the 
presence of persisting FDC-associated antigen. This is sup- 
ported  by  the  findings  (a)  long-lived  GC  are  associated 
with persisting antigen, (b) that VSV-specific AFC are only 
found  in  lymphoid  organs  containing  persisting  antigen, 
and (c) that memory anti-VSV IgG levels can be increased 
by antigen-antibody complexes that bind to  FDC  (5,  6). 
These  results  on  the  role  of antigen  complexes in  local 
lymphoid organs persisting bound to .FDCs  extend those 
obtained earlier with carrier hapten antigens injected in ad- 
juvants  or complexed with  antibodies  (3,  4,  10,  11,  24). 
Since viral antigens  seem to maintain such long-term mem- 
ory without adjuvants our results  suggest that viral antigens 
may have evolved to persist for a long time possibly by be- 
ing relatively resistant to degradation, when compared to 
immunological model antigens. 
It has been shown previously that memory B cells recir- 
culate  throughout  the  lymphatic  tissue  whereas  antibody 
forming cells are restricted to the sites of antigen persistence 
(and the bone marrow)  (6,  10,  29). Memory AFC induc- 
tion may therefore reflect: (a) recirculating B  cells migrate 
through the lymphatic tissue and differentiate to AFC when- 
ever they encounter persisting antigen.  (b)  There are two 
distinct sets of memory B  cells, one population of recircu- 
lating B cells that do not proliferate and that are detected in 
classical adoptive transfer experiments and a second popula- 
tion of memory B cells that remain associated with persist- 
ing  antigen,  proliferate  and  differentiate  to  AFC.  These 
AFC then either migrate to the red pulp/marginal zone or 
eventually to the bone marrow. 
The finding of long-lived GC associated with persisting 
antigen on FDC presented here supports the latter model. 
Ifrecirculating memory B cells differentiated to AFC when- 
ever they encounter persisting antigen, one would not ex- 
pect GC like structures with a high concentration of spe- 
cific B  cells as found here with high rates of proliferation, 
but rather fewer specific B  cells  as found in the study by 
Liu et al. for hapten specific B  cells 7 wk after immuniza- 
tion (24).  Our data are probably also  compatible with the 
previously published observation that most memory B cells 
apparently do  not proliferate  (9).  In  this particular study, 
phycoerythrin was used as a hapten to induce memory B 
cells.  Since haptens induced short-lived GC and since no 
long-lived antibody titers are usually measurable in the ab- 
sence of an antigen depot in adjuvants, this report probably 
analyzed predominantly the population of non-cycling but 
recirculating memory B cells. 
It should be pointed out that antibody-mediated protec- 
tive immunity not only depends on the presence of mem- 
ory B cells, but requires preexisting specific antibody at suf- 
ficiently high  titers.  In  many  cases,  preexisting antibody 
prevents a secondary infection completely, whereas mem- 
ory B cells may only enhance kinetics of pathogen efimina- 
tion  without  alone  being  protective  (1,  2).  As  discussed 
previously for hapten-carrier in adjuvants (3, 4, 10,  12) and 
here for viral antigens without adjuvant, the maintenance of memory antibody  titers  may strictly  depend  upon  the 
presence  of persisting  antigen,  whereas  resting memory B 
cells appear to be less antigen-dependent.  This suggests that 
only memory B  cells  activated by persisting antigen differ- 
entiate  to AFC and produce and maintain protective anti- 
body levels.  These protective antibody responses may there- 
fore  result  from  coevolution  of the  critical  neutralizing 
epitopes to persist in the host so that high levels of antibod- 
ies  are  maintained.  These  antibodies  are  also  essential  for 
transmission of passive protection by the mother to immu- 
nodeficient offspring during maturation of their T  cell im- 
munity (45). 
Overall,  there is  a parallel  to memory cytotoxic T  cells 
where physical presence of memory cytotoxic T  cells seems 
to be independent of  persisting antigen (46, 47). These mem- 
ory cytotoxic T  cells  may circulate in the blood; however, 
they only recirculate through tissue and mediate protective 
immunity peripherally if activated by persisting antigen (48). 
In summary, immunization with VSV leads to long-lived 
GC associated with FDC that most probably are responsi- 
ble  for  the  maintenance  of the  memory  IgG  titer.  This 
demonstrates  that  subpopulations  of memory B  cells  may 
not be static (non-proliferating) but may be highly dynamic 
and actively proliferating locally in GC. 
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